Preoperative Thyroid Autoimmune Status and Changes in Thyroid Function and Body Weight After Bariatric Surgery

Area of Science:

• Endocrinology
• Metabolic Surgery
• Immunology

Background:

• Morbid obesity is a significant health concern, with bariatric surgery as a primary treatment.
• Emerging evidence suggests bariatric surgery impacts systemic inflammation and thyroid function.
• The role of preoperative thyroid autoimmune status in post-bariatric surgery outcomes requires further investigation.

Purpose of the Study:

• To investigate the association between preoperative thyroid autoimmune status and changes in body weight and thyroid function following bariatric surgery.
• To identify potential predictors of surgical outcomes in patients with morbid obesity and thyroid autoimmunity.

Main Methods:

• 101 patients with morbid obesity undergoing bariatric surgery were recruited, excluding those on thyroid medication.
• General linear models were employed to compare changes in body weight and thyroid function based on preoperative thyroid autoimmune status.
• Serum levels of free triiodothyronine (FT3), thyroid-stimulating hormone (TSH), and thyroid antibodies (TPOAb, TgAb) were analyzed.

Main Results:

• Bariatric surgery led to significant reductions in BMI, FT3, TSH, and improved lipid profiles.
• Participants with positive thyroid autoimmunity showed a significant decrease in TPOAb and TgAb levels post-surgery.
• Positive preoperative thyroid autoimmunity was associated with a less pronounced reduction in TSH and BMI compared to those without autoimmunity.

Conclusions:

• Bariatric surgery is effective for morbid obesity, influencing thyroid function and autoimmunity.
• Patients with positive preoperative thyroid autoimmunity may experience less significant reductions in TSH and body weight after surgery.
• These findings identify a specific subgroup of patients who may require tailored monitoring and management post-bariatric surgery.